Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Kenvue Inc | 73 |
| 2 | Croda International PLC | 71 |
| 3 | Johnson and Johnson | 71 |
| 4 | Cargill Inc | 48 |
| 5 | Procter and Gamble Co | 48 |
| 6 | Unilever PLC | 48 |
| 7 | L'Oréal SA | 47 |
| 8 | Asahi Kasei Corp | 40 |
| 9 | Massachusetts Institute of Technology | 28 |
| 10 | Pfizer Inc | 27 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 989 |
| 2 | A61P | Therapeutic activity (drug indications) | 665 |
| 3 | A61Q | Cosmetics, personal care | 483 |
| 4 | C12N | Microorganisms, enzymes | 416 |
| 5 | G01N | Investigating / analysing materials | 331 |
| 6 | C07K | Peptides | 218 |
| 7 | C07D | Heterocyclic compounds | 204 |
| 8 | C12P | Fermentation, enzyme processes | 178 |
| 9 | C12Q | Measuring/testing involving enzymes | 175 |
| 10 | C12Y | Enzyme nomenclature (EC numbers) | 146 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Preparing Method of 4-hydroxyphenyllactic Acid Using Variant Microorganism | 2016 | 1 | |
| 4-HYDROXYPHENYLLACTIC ACID FOR USE IN TREATING AND REDUCING THE RISK OF IGE-MEDIATED DISEASES | 2025 | 0 | |
| Preparing Method of 4-hydroxyphenyllactic Acid Using Variant Microorganism | 2018 | 0 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 5 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Vares Im | 3 | |
| 2 | Baĭkova Vn | 2 | |
| 3 | Brendan P. Norman | University of Liverpool | 2 |
| 4 | A. T. Hendry | Hamilton General Hospital | 2 |
| 5 | Sanjay K. Nigám | University of California San Diego | 2 |
| 6 | Roy A. Jensen | University of Florida | 2 |
| 7 | Toshiyuki Kawasumi | Japan Women's University | 2 |
| 8 | Cristina Nowicki | Instituto de Química y Fisicoquímica Biológicas | 2 |
| 9 | Nicholas Day | University of Oxford | 2 |
| 10 | Chise Suzuki | Institute of Livestock and Grassland Science | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Purification and Characterization of Novel Antifungal Compounds from the Sourdough Lactobacillus plantarum Strain 21B | 2000 | 631 | Probiotics and Fermented Foods |
| Link between gut‐microbiome derived metabolite and shared gene‐effects with hepatic steatosis and fibrosis in NAFLD | 2018 | 203 | Liver Disease Diagnosis and Treatment |
| Activation of a G protein–coupled receptor by its endogenous ligand triggers the innate immune response of Caenorhabditis elegans | 2014 | 146 | Genetics, Aging, and Longevity in Model Organisms |
| Microbial origin of phenylcarboxylic acids in the human body | 2009 | 142 | Gut microbiota and health |
| Application of Lactobacillus amylovorus DSM19280 in gluten-free sourdough bread to improve the microbial shelf life | 2014 | 127 | Food composition and properties |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of hydroxyphenyllactate?
Which organizations hold the most patents related to hydroxyphenyllactate?
How has patent activity for hydroxyphenyllactate changed in recent years?
What are the main research topics associated with hydroxyphenyllactate publications?
What patent classification areas dominate hydroxyphenyllactate intellectual property?